\ Gastric Ulcers - Pipeline Insight, 2018 - ResearchAndMarkets.com
Company News: Page (1) of 1 - 09/14/18

Gastric Ulcers - Pipeline Insight, 2018 - ResearchAndMarkets.com

September 14, 2018 --

DUBLIN--(BUSINESS WIRE)--The "Gastric Ulcers - Pipeline Insight, 2018" drug pipelines has been added to ResearchAndMarkets.com's offering.


This report offers a comprehensive insight of the pipeline (under development) therapeutics scenario and growth prospects across Gastric Ulcers development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Scope



  • The report provides a snapshot of the pipeline development for Gastric Ulcers
  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for Gastric Ulcers
  • The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Gastric Ulcers
  • The report also covers the dormant and discontinued pipeline projects related to Gastric Ulcers

Companies Featured

  • Astellas Pharma Inc.
  • Boryung Pharmaceutical Co Ltd.
  • ChoDang Pharm Co. Ltd.
  • Daewoong Pharmaceutical Co. Ltd.
  • Kukje Pharmaceutical Industry Co. Ltd.
  • RaQualia Pharma Inc.
  • XuanZhu Pharma Co. Ltd.
  • CJ HealthCare Corporation
  • Takeda

Key Topics Covered

1. Report Introduction

2. Gastric Ulcers Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Gastric Ulcers

4. Comparative Analysis

5. Products in Clinical Stage
5.1 Drug Name: Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name: Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products
8.1 Drug Name: Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/pdz2mq/gastric_ulcers?w=4


Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Gastrointestinal Drugs

Page: 1
Related Keywords:

Source:Copyright (c) Business Wire.. All Rights Reserved

Our Privacy Policy --- @ Copyright, 2017 Digital Media Online, All Rights Reserved

Webmaster
Privacy.